45 min listen
Developing Non-Traditional Antibiotics (AAC ed.)
Developing Non-Traditional Antibiotics (AAC ed.)
ratings:
Length:
41 minutes
Released:
Mar 19, 2021
Format:
Podcast episode
Description
Developing non-traditional antibiotics promises novel strategies to combat multidrug-resistant organisms but would they work? Are they feasible to develop? Topics discussed:
• The notion of non-traditional antibiotics as potential therapeutics against MDR organisms
• Increasing our understanding on the clinical efficacy of non-traditional antibiotics
• Regulatory pathways for approval of such compounds
Guest: Dr. John Rex, Chief Medical Officer, F2G Ltd. | Editor-in-Chief, AMR.solutions Visit https://aac.asm.org to browse issues and/or submit a manuscript.
Released:
Mar 19, 2021
Format:
Podcast episode
Titles in the series (81)
Detection of carbapenemases (JCM ed.): • How can the clinical laboratory detect carbapenemases, which are enzyme that can make bacteria resistant to some of the most potent or broad-spectrum antibiotics available? • What is the clinical significance of detecting such an enzyme? Does it... by Editors in Conversation